You have 9 free searches left this month | for more free features.

Leukemia, Promyelocytic, Acute

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral arsenic Trioxide, ATRA and ascorbic acid
  • Hong Kong, N/A = Not Applicable, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Nov 3, 2020

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Results From a Mexican Acute Promyelocytic Leukemia.

Completed
  • Promyelocytic Leukemia, Acute
  • Diagnosis
  • +2 more
  • Mexico, Mexico City, Mexico
    Nidia Zapata
Sep 18, 2020

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

Recruiting
  • Acute Promyelocytic Leukemia
  • all-trans retinoic acid (ATRA)
  • Bari, Italy
  • +2 more
Oct 12, 2020

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Safety and Efficacy Trial in Suzhou (Ruxolitinib)

Unknown status
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Jun 22, 2020

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

Recruiting
  • Acute Promyelocytic Leukemia
  • Arsenic Trioxide
  • Alessandria, Italy
  • +27 more
Dec 31, 2021

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

Active, not recruiting
  • Acute Promyelocytic Leukemia
  • QoL questionnaires
  • Ascoli Piceno, Italy
  • +15 more
Feb 3, 2021

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Feb 3, 2020

    Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

    Active, not recruiting
    • Leukemia
    • +2 more
    • laboratory biomarker analysis
    • San Diego, California
    • +50 more
    Aug 16, 2021

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Acute Promyelocytic Leukaemia Trial (Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid)

    Not yet recruiting
    • Acute Promyelocytic Leukaemia
    • Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
    • (no location specified)
    Nov 26, 2019

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

    Completed
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +10 more
    • Erlotinib Hydrochloride
    • Laboratory Biomarker Analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 18, 2019

    Pregnancy in Acute Promielocitic Leukaemia Patients Treated With

    Recruiting
    • Acute Promyelocytic Leukemia
    • Pregnancy
      • Alessandria, Italy
      • +36 more
      Dec 31, 2021

      Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

      Active, not recruiting
      • Childhood Acute Promyelocytic Leukemia (M3)
      • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
      • arsenic trioxide
      • +7 more
      • Birmingham, Alabama
      • +110 more
      Mar 23, 2022

      Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

      Active, not recruiting
      • Leukemia
      • arsenic trioxide
      • +5 more
      • Innsbruck, Austria
      • +109 more
      Dec 31, 2021

      Acute Promyelocytic Leukemia Trial in Shanghai (ATRA+Arsenic, ATRA+Chemo)

      Unknown status
      • Acute Promyelocytic Leukemia
      • Shanghai, China
        Department of Hematology
      Aug 15, 2019